Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Leases (2019 - 2023)

Historic Leases for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $10.3 million.

  • ADC Therapeutics' Leases rose 5313.06% to $10.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $10.3 million, marking a year-over-year increase of 5313.06%. This contributed to the annual value of $6.9 million for FY2022, which is 9628470.13% up from last year.
  • Latest data reveals that ADC Therapeutics reported Leases of $10.3 million as of Q3 2023, which was up 5313.06% from $11.0 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Leases peaked at $11.2 million during Q1 2023, and registered a low of $3402.0 during Q3 2020.
  • Its 5-year average for Leases is $5.9 million, with a median of $6.8 million in 2022.
  • Its Leases has fluctuated over the past 5 years, first skyrocketed by 22153433.27% in 2021, then tumbled by 2455.12% in 2022.
  • Quarter analysis of 5 years shows ADC Therapeutics' Leases stood at $4898.0 in 2019, then crashed by 30.54% to $3402.0 in 2020, then surged by 110.58% to $7164.0 in 2021, then surged by 96284.7% to $6.9 million in 2022, then surged by 48.76% to $10.3 million in 2023.
  • Its last three reported values are $10.3 million in Q3 2023, $11.0 million for Q2 2023, and $11.2 million during Q1 2023.